Microencapsulation of an anti-VE-cadherin antibody secreting 1B5 hybridoma cells

Biotechnology and Bioengineering

Volumn 76, Issue 4, 2001, Pages 285-294

  Orive, G ^a   Hernandez R M ^a   Gascon A R ^a   Igartua, M ^a   Rojas, A ^b   Pedraz, J L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Center of Pharmaceutical Chemistry Cuba   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; BIOLOGICAL MEMBRANES; CELL IMMOBILIZATION; TUMORS;

ANGIOGENESIS;

MONOCLONAL ANTIBODIES;

AGAROSE; ALGINIC ACID; ANGIOGENESIS INHIBITOR; CADHERIN; MONOCLONAL ANTIBODY VE CADHERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG DELIVERY SYSTEM; HYBRIDOMA; IMMOBILIZED CELL; MICROENCAPSULATION; MICROTUBULE; MOLECULAR STABILITY; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ALGINATES; ANGIOGENESIS INHIBITORS; ANTIBODIES; ANTIGENS, CD; CADHERINS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYBRIDOMAS; LAMININ; POLYLYSINE; PROTEOGLYCANS; SEPHAROSE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0035829828     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10050     Document Type: Article

References (77)

1. Long-term cross-species brain transplantation of a polymer encapsulated dopamine-secreting cell line
2. Tumor and endothelial cell invasion of basement membranes
3. Successful pancreatic xenografts using semipermeable membrane
4. Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of bening human insulinomas
5. Tight junctions and the molecular basis for regulation of paracellular permeability
6. The agarose double helix and its function in gel structure
7. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels
8. Partial correction of murine mucopolysaccaridosis VII with micro-encapsulated non-autologous recombinant fibroblast
9. Factors promoting tumor angiogenesis
10. Methods for animal cell immobilization using electrostatic droplet generation
11. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
12. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin)
13. Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation
14. Implantable biohybrid artificial organs
15. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo
16. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogencsis
17. Improved biocompatibility but limited graft survival after purification of alginates for microencapsulation of pancreatic islets
18. Immobilization of murine lymphocytes by gel entrapment
19. Alginate based new materials
20. Junctional complexes in various epithelia
21. Tumor angiogenesis: Therapeutic implications
22. Anti-angiogenesis: New concept for therapy of solid tumors
23. Tumor angiogenesis
24. Cadherins
25. New processes and actual trends in biotechnology
26. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
27. Vascular Endothelial Cadherin (CD144) but not PECAM-I (CD31)-based cell-to-cell contacts convey the maintenance a quiescent endothelial monolayer
28. Parathyroid allotransplantation without immunosuppression
29. First successful xenotransplantation of microencapsulated human parathyroid tissue in experimental hypoparathyroidism: Long-term function without immunosuppression
30. Delivery of human factor IX in mice by encapsulated recombinant myoblast: A novel approach towards allogeneic gene therapy of hemophilia B
31. Persistent delivery of factor IX in mice: Gene therapy for hemophilia using implantable microcapsules
32. Gene therapy for hemophilia
33. Biomaterials in tissue engineering
34. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion
35. Application of electric field for production of immobilized biocatalysts
36. Regulators of angiogenesis
37. Gene therapy strategies for tumor antiangiogenesis
38. Interendothelial junctions: Structure, signalling and functional roles
39. Perspectives in diabetes. Islet transplantation with immunoisolation
40. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres
41. Transplantation of encapsulated cells and tissues
42. Cell culture conditions determine the enhancement of specific monoclonal antibody productivity of calcium alginate entrapped S3H5/g2bA2 hybridomas cells
43. Enhancement specific antibody productivity of calcium alginate-entrapped hybridoma is cell line specific
44. Characterization of modified alginate-poly-L-lysine microcapsules
45. Transport characterization of hydrogel matrices for cell encapsulation
46. Microencapsulated islets as bioartifial endocrine pancreas
47. Generation of alginate-poly-L-lysine (APA) biomicrocapsules: The relationship between the membrane strength and the reaction conditions
48. Molecular and cellular mechanism of angiogenesis
49. Successful treatment of diabetes with the biohybrid artificial pancreas in dogs
50. Proteolytic balance and capillary morphogenesis in vitro
51. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays
52. Encapsulation of various recombinant mammalian cell types in different microcapsules
53. A parallel plate electrostatic droplet generator: Parameters affecting microbead size
54. Microencapsulation technology for large scale antibody production
55. Immunocompatibility and biocompatibility of cell delivery systems
56. Effect of oxygen limitations on monoclonal antibody production by immobilized hybridoma cells
57. Mechanism of angiogenesis
58. Alginate-poly-L-lysine microcapsule biocompatibility: A novel RT-PCR method for cytokine gene expression analysis in pericapsular infiltrates
59. Studies on small (<350 μm) alginate-poly-L-lysine microcapsules. III. Biocompatibility of smaller versus standard microcapsules
60. Entrepment of animal cells for the production of biomolecules such as monoclonal antibodies
61. Hybridoma cells in a protein-free medium within a composite gel perfusion bioreactor
62. Calcium alginate immobilized hybridomas grown using a fluidized-bed perfusion system with a protein-free medium
63. Alginate as immobilization matrix for cells
64. Chemistry and physical properties of alginates
65. Measurement of protein using bicinchoninic acid
66. Long-term reversal of diabetes by the injection of immunoprotected islets
67. Biohybrid artificial pancreas: Long term implantation studies in diabetic, pancreatectomized dogs
68. Diffusion characteristics of substrates in Ca-alginate gel beads
69. Alginate polycation microcapsules. I. Interaction between alginate and polycation
70. Alginate polycation microcapsules. II. Some functional properties
71. Colorimetric assay for cellular activity in microcapsules
72. Technology of mammalian cell encapsulation
73. Biotechnology and the discovery of new anticancer drugs. I. Locating new targets
74. Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles